News | Colonoscopy Systems | July 18, 2016

CDC study shows facilities can reach target of 80 percent screening for adults 50-75, but only half of adults are up-to-date on screening

CDC study, colorectal cancer screening goals, Djenaba Joseph

July 18, 2016 — U.S. government agencies and their colorectal cancer prevention have set a goal that at least 80 percent of adults ages 50-75 will be screened for colorectal cancer. A recently published study conducted by researchers at the Centers for Disease Control and Prevention (CDC) shows that the U.S. healthcare system has the capacity to make this goal a reality.

To determine if the U.S. could expand its screening capacity, CDC researchers used mathematical modeling to estimate the number of colonoscopies or fecal immunochemical tests (FIT) that would be necessary every year to screen for colorectal cancer for 80 percent of adults in the recommended age group. They found that 5.1 million to 13 million colonoscopies would need to be conducted per year, depending on which screening test was first used.

The analysis also used survey data from facilities that perform colonoscopies to determine the number of colonoscopies that are performed in the U.S. every year — and to calculate how many more they could do. This survey showed that 15 million colonoscopies were performed in the U.S. in 2012, and that another 10.5 million colonoscopies could be performed every year.

“Colorectal cancer is the second leading cancer killer for men and women in the U.S., but it doesn’t have to be,” said Djenaba Joseph, M.D., MPH, medical director of the colorectal cancer control program at CDC and lead author of the paper. “Screening saves lives. The good news is that our modeling shows that the U.S. healthcare system has the potential to meet our national goal of screening 80 percent of adults ages 50-75.  Ask your doctor about screening — there are several options now.”

Of the cancers affecting both men and women, colorectal cancer (cancer of the colon or rectum) is the second-leading cancer killer in the U.S., according to the CDC. Screening can find precancerous polyps — abnormal growths in the colon or rectum — so they can be removed before turning into cancer. Screening also helps find colorectal cancer at an early stage, when it is easier to treat.

The U.S. Preventive Services Task Force (USPSTF) recently reinforced its recommendations that adults ages 50-75 be screened for colorectal cancer.  This recommendation continues to receive USPSTF’s highest rating — an “A” grade, indicating that the evidence is convincing that screening for colorectal cancer has substantial benefits. But only a little more than half of the target population is up-to-date with screening.

The new study, “Colorectal Cancer Screening: Estimated Future Colonoscopy Need and Current Volume and Capacity,” is published online in the journal Cancer.

For more information: www.onlinelibrary.wiley.com


Related Content

News | Colonoscopy Systems

A team of Johns Hopkins data researchers is studying the economic and safety implications associated with the devices used to perform colonoscopies as a disposable version inches closer to widespread availability.

Time August 26, 2019
arrow
News | Colonoscopy Systems

A new study finds that trends in colonoscopy rates did not fully align with the increase in colorectal cancer (CRC) in younger adults, adding to evidence that the rise in early onset CRC is not solely a result of more detection. The study is published early online in the Journal of Medical Screening.

Time August 06, 2019
arrow
News | Colonoscopy Systems

Check-Cap Ltd. has initiated its U.S. pilot study of the C-Scan system for prevention of colorectal cancer through detection of precancerous polyps, following Institutional Review Board (IRB) approval and full Investigational Device Exemption (IDE) application approval by the U.S. Food and Drug Administration (FDA). The first patients have ingested C-Scan, a preparation-free capsule, at the New York University School of Medicine.

Time April 15, 2019
arrow
News | Colonoscopy Systems

https://www.congress.gov/bill/115th-congress/house-bill/1298?q=%7B%22se… cancer care advocacy groups and medical societies are calling on Congress to pass the CT Colonography Screening for Colorectal Cancer Act (S.3465/HR 1298). The bipartisan bill introduced in the U.S. Senate September 19 would provide Medicare coverage for screening computed tomography colonography (CTC), commonly known as virtual colonoscopy.

Time September 27, 2018
arrow
News | Colonoscopy Systems

Check-Cap Ltd. announced the interim results for its post-CE approval study of the C-Scan system Version 3, an ingestible, capsule-based device for preparation-free colorectal cancer (CRC) screening. The company said data from the multicenter clinical investigation showed promising results for detecting patients with polyps in an un-prepped colon.

Time September 04, 2018
arrow
News | Colonoscopy Systems

An updated American Cancer Society guideline says colorectal cancer screening should begin at age 45 for people at average risk. The recommendation is based in part on data showing rates of colorectal cancer are increasing in young and middle-aged populations.

Time May 30, 2018
arrow
News | Colonoscopy Systems

February 8, 2018 – The U.S. Food and Drug Administration (FDA) announced on February 7, 2018, that Pentax Medical’s ...

Time February 08, 2018
arrow
News | Colonoscopy Systems

August 31, 2017 — A fast, simple blood test for ulcerative colitis using infrared spectroscopy could provide a cheaper ...

Time August 31, 2017
arrow
News | Colonoscopy Systems

People with insurance policies that cover computed tomography (CT) colonography for colorectal cancer screening are almost 50 percent more likely to get screened than those whose policies don’t cover the procedure, according to a new study appearing online in the journal Radiology.

Time July 12, 2017
arrow
Feature | Computed Tomography (CT) | By Jeff Zagoudis

Computed tomography colonography (CTC), also known as virtual colonoscopy, offers a noninvasive alternative to traditional (optical) colonoscopy for detection of precancerous polyps. The technology has been around for over 20 years, and numerous studies have shown it to be effective for diagnosis and screening. Questions about its utility as a screening tool persist, however, as the Centers for Medicare and Medicaid Services (CMS) reiterated in December that it will not reimburse providers for CTC in that role. The radiology community is working to change that by finding ways to improve the procedure and educating patients and providers.

Time July 05, 2017
arrow
Subscribe Now